N/A
N=880
Tools for Anxiety and Depression Screening in Epilepsy
Epilepsy
Bottom Line
View on ClinicalTrials.gov: NCT05864612 ↗Enrolled (actual)
880
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcome: Primary: Percentage of Subjects Completing Screening Instruments — 0; 14; 19; 12 Percentage who completed
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Screening Questionnaires (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Wake Forest University Health Sciences
- Primary completion
- Sep 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Subjects Completing Screening Instruments |
0; 14; 19; 12 | — |
| SECONDARY Research Team Time-sending Instruments |
3.0; 4.5; 1.7; 0.6 | — |
| SECONDARY Research Team Time-instrument Data Entry |
2.5; 1.8; 1.7 | — |
| SECONDARY Participant Time From Instrument Delivery to Completion |
4.6; 3.1; 2.2 | — |
| SECONDARY Percent Accuracy of Kit Application Programming Interface (API) |
100; 100 | — |
Summary
A randomized trial to compare patient-completion success of REDCap and Electronic Health Record (EHR)-based anxiety & depression instrument delivery methods. Study hypothesis is that the screening completion proportion will vary across the 4 modalities tested.
Eligibility Criteria
Inclusion Criteria
- Visit scheduled 7 days in advance at an adult-focused epilepsy clinic at the study site
Exclusion Criteria
- No exclusions
Data sourced from ClinicalTrials.gov (NCT05864612). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.